P809: BASELINE CHARACTERISTICS IDENTIFYING PATIENTS WITH MULTIPLE MYELOMA TREATED WITH IDECABTAGENE VICELEUCEL (IDE-CEL; BB2121) WHO ARE AT RISK FOR SEVERE/REFRACTORY INFLAMMATORY ADVERSE EVENTS

Bibliographic Details
Main Authors:	Afshin Mashadi-Hossein, Julie Rytlewski, MD Shamsuzzaman, Debashree Basudhar, Mandeep Takhar, Ana Kostic, Timothy B. Campbell, Salomon Manier, Yi Lin, Nathan Martin
Format:	Article
Language:	English
Published:	Wiley 2023-08-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000970140.10042.07

Internet